[go: up one dir, main page]

WO1996021675A3 - Capture de micro-organismes a l'aide de constituants du complement - Google Patents

Capture de micro-organismes a l'aide de constituants du complement Download PDF

Info

Publication number
WO1996021675A3
WO1996021675A3 PCT/EP1996/000137 EP9600137W WO9621675A3 WO 1996021675 A3 WO1996021675 A3 WO 1996021675A3 EP 9600137 W EP9600137 W EP 9600137W WO 9621675 A3 WO9621675 A3 WO 9621675A3
Authority
WO
WIPO (PCT)
Prior art keywords
microorganisms
capturing
complement components
relates
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/000137
Other languages
English (en)
Other versions
WO1996021675A2 (fr
Inventor
Paul Herbrink
Den Munckhof Henk Van
Wilhelmus Quint
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
DDL Diagnostic Laboratory BV
Original Assignee
Innogenetics NV SA
DDL Diagnostic Laboratory BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA, DDL Diagnostic Laboratory BV filed Critical Innogenetics NV SA
Priority to AU45358/96A priority Critical patent/AU4535896A/en
Priority to EP96901269A priority patent/EP0873358A2/fr
Publication of WO1996021675A2 publication Critical patent/WO1996021675A2/fr
Publication of WO1996021675A3 publication Critical patent/WO1996021675A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention se rapporte au domaine de la détection de micro-organismes pathogènes dans des échantillons biologiques, et plus particulièrement à l'utilisation de constituants du complément ou de fragments de celui-ci, éventuellement liés à une phase solide, pour capturer une large gamme de micro-organismes à partir d'un échantillon, lesdits constituants du complément étant de préférence C1 ou C1Q ou C3b. L'invention se rapporte également à ces mêmes constituants utiles dans la préparation d'un dispositif, agent ou nécessaire de diagnostic.
PCT/EP1996/000137 1995-01-13 1996-01-15 Capture de micro-organismes a l'aide de constituants du complement Ceased WO1996021675A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU45358/96A AU4535896A (en) 1995-01-13 1996-01-15 Capturing of microorganisms using complement components
EP96901269A EP0873358A2 (fr) 1995-01-13 1996-01-15 Capture de micro-organismes a l'aide de constituants du complement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95870004 1995-01-13
EP95870004.9 1995-01-13

Publications (2)

Publication Number Publication Date
WO1996021675A2 WO1996021675A2 (fr) 1996-07-18
WO1996021675A3 true WO1996021675A3 (fr) 1996-11-14

Family

ID=8222112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/000137 Ceased WO1996021675A2 (fr) 1995-01-13 1996-01-15 Capture de micro-organismes a l'aide de constituants du complement

Country Status (3)

Country Link
EP (1) EP0873358A2 (fr)
AU (1) AU4535896A (fr)
WO (1) WO1996021675A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3538897A (en) * 1996-07-12 1998-02-09 Fresenius Ag Selective adsorbent for binding retroviruses
AT409801B (de) * 2000-05-31 2002-11-25 Cistem Biotechnologies Gmbh Verfahren zum screenen und isolieren von mikroorganismen, insbesondere prokaryontischer und eukaryontischer zellen, die ein antigen präsentieren
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays
US20030044771A1 (en) * 2001-08-30 2003-03-06 Anderson Norman G. Method for discovering new infectious particles
CN109536585A (zh) * 2018-12-10 2019-03-29 吴江近岸蛋白质科技有限公司 细胞一步法实时定量pcr的方法、配套试剂盒及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002063A1 (fr) * 1985-10-04 1987-04-09 Immunicon Corporation Particules magnetiques-polymeres
US4693967A (en) * 1981-02-18 1987-09-15 Research Corporation Monitoring therapy results in body samples of receptor cells
EP0605003A2 (fr) * 1992-12-31 1994-07-06 Vicam, L.P. Méthode d'essai pour détecter la présence de bactéries

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693967A (en) * 1981-02-18 1987-09-15 Research Corporation Monitoring therapy results in body samples of receptor cells
WO1987002063A1 (fr) * 1985-10-04 1987-04-09 Immunicon Corporation Particules magnetiques-polymeres
EP0605003A2 (fr) * 1992-12-31 1994-07-06 Vicam, L.P. Méthode d'essai pour détecter la présence de bactéries

Also Published As

Publication number Publication date
WO1996021675A2 (fr) 1996-07-18
AU4535896A (en) 1996-07-31
EP0873358A2 (fr) 1998-10-28

Similar Documents

Publication Publication Date Title
WO2000020846A8 (fr) Procede d'imagerie de tissus
EP0961110A3 (fr) Dispositif de préparation d'échantillons liquides de faible épaisseur en vue d'une analyse microscopique
CA2263888A1 (fr) Procedes et compositions servant a detecter le cancer du col de l'uterus
WO2002090539A3 (fr) Compositions, methodes et trousses permettant d'isoler des acides nucleiques au moyen de tensioactifs et de proteases
EP2267019A3 (fr) Polypeptides de liaison pour la protéine stimulatrice des lymphocytes B (BLyS)
AU7419996A (en) Device for removing toxic substances from the blood
YU73600A (sh) Novi nukleosidi koji imaju biciklične šećerne grupe
CA2111853A1 (fr) Molecules pratiquement pures de type recepteurs, permettant la fixation de la molecule tgf-.beta.1, avec leur utilisation
FI963410A0 (fi) Laite nestemäisten näytteiden, kuten verinäytteideLaite nestemäisten näytteiden, kuten verinäytteiden ottamiseksi ja analysoimiseksi n ottamiseksi ja analysoimiseksi
CA2406745A1 (fr) Methode de depistage et/ou d'identification de sequences de virus adeno-associes (aav) et isolation des sequences nouvelles ainsi identifiees
WO2005045075A3 (fr) Procedes de preparation d'echantillons et dispositifs associes
ZA996078B (en) Assay device processing instrument.
WO2002084250A3 (fr) Procedes de detection par spectrometrie de masse et quantification de proteines cibles specifiques dans des echantillons biologiques complexes
AU1741800A (en) Apparatus for taking blood samples
DE69735600D1 (de) Konservierung empfindlicher biologischer proben durch verglasung
EP1679383A3 (fr) Procédé et dispositif pour la purification d'acides nucléiques
AU2002364120A1 (en) Sensor for the use in testing biological chemical or environmental samples
WO2001057537A3 (fr) Procedes servant a diagnostiquer la maladie d'alzheimer
AU2961502A (en) Device for desintegrating biological samples
WO1997012039A3 (fr) Inositol-phosphatase contenant le site sh2
WO1996021675A3 (fr) Capture de micro-organismes a l'aide de constituants du complement
WO1999013330A3 (fr) Epuration de substances provenant d'un echantillon biologique
ZA961704B (fr)
WO2001041813A3 (fr) Procedes de traitement de lupus sur la base de l'affinite aux anticorps et procedes de criblage et compositions associees
CA2406443A1 (fr) Methode de quantification de l'expression de proteine akt

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KG KZ RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KG KZ RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE

WWE Wipo information: entry into national phase

Ref document number: 1996901269

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996901269

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996901269

Country of ref document: EP